JACC-CI study & ACC Distinguished Award winner evidence T3 leads the way in preclinical cardiovascular research
T3 Labs is committed to excellence in translational research including preclinical cardiovascular research. After all, our program leaders are scientists, too. This is most recently evident in the journal article “Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent…